WallStreetZenWallStreetZen

NASDAQ: TBPH
Theravance Biopharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TBPH

Based on 5 analysts offering 12 month price targets for Theravance Biopharma Inc

Min Forecast
$20.00+13.57%
Avg Forecast
$27.80+57.86%
Max Forecast
$40.00+127.14%

Should I buy or sell TBPH stock?

Based on 5 analysts offering ratings for Theravance Biopharma Inc.

Strong Buy
Strong Buy
3 analysts 60%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their TBPH stock forecasts and price targets.

TBPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-03
lockedlocked$00.00+00.00%2025-11-26Find Out Why
lockedlocked$00.00+00.00%2025-11-11
lockedlocked$00.00+00.00%2025-09-12Find Out Why
lockedlocked$00.00+00.00%2025-06-17

1 of 1

Forecast return on equity

Is TBPH forecast to generate an efficient return?

Company
17.92%
Industry
255.07%
Market
226.45%
TBPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TBPH forecast to generate an efficient return on assets?

Company
10.04%
Industry
91.01%
TBPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TBPH earnings per share forecast

What is TBPH's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$1.92+230.66%
Avg 2 year Forecast
$0.96+66.36%
Avg 3 year Forecast
$0.08-86.59%
TBPH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

TBPH revenue forecast

What is TBPH's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$110.0M+36.88%
Avg 2 year Forecast
$88.6M+10.3%
Avg 3 year Forecast
$124.1M+54.44%
TBPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TBPH earnings growth forecast

How is TBPH forecast to perform vs Biotechnology companies and vs the US market?

Company
-48.81%
Industry
44.08%
Market
42.53%
TBPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
TBPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
TBPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

TBPH revenue growth forecast

How is TBPH forecast to perform vs Biotechnology companies and vs the US market?

Company
15.59%
Industry
102.3%
Market
25.86%
TBPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TBPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TBPH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TBPH$17.61$27.80+57.86%Strong Buy
IOVA$2.26$12.25+442.04%Strong Buy
YDES$12.64N/AN/A
ABUS$4.59$5.00+8.93%Strong Buy
GHRS$14.21$31.00+118.16%Buy
View Top Biotech Stocks

Theravance Biopharma Stock Forecast FAQ

Is Theravance Biopharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: TBPH) stock is to Strong Buy TBPH stock.

Out of 5 analysts, 3 (60%) are recommending TBPH as a Strong Buy, 2 (40%) are recommending TBPH as a Buy, 0 (0%) are recommending TBPH as a Hold, 0 (0%) are recommending TBPH as a Sell, and 0 (0%) are recommending TBPH as a Strong Sell.

If you're new to stock investing, here's how to buy Theravance Biopharma stock.

What is TBPH's earnings growth forecast for 2025-2027?

(NASDAQ: TBPH) Theravance Biopharma's forecast annual earnings growth rate of -48.81% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 44.08%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.53%.

Theravance Biopharma's earnings in 2025 is $29,344,000.On average, 8 Wall Street analysts forecast TBPH's earnings for 2025 to be $97,179,588, with the lowest TBPH earnings forecast at $69,522,575, and the highest TBPH earnings forecast at $119,769,358. On average, 8 Wall Street analysts forecast TBPH's earnings for 2026 to be $48,893,829, with the lowest TBPH earnings forecast at $9,435,207, and the highest TBPH earnings forecast at $69,167,868.

In 2027, TBPH is forecast to generate $3,942,315 in earnings, with the lowest earnings forecast at -$44,196,494 and the highest earnings forecast at $72,892,292.

What is TBPH's revenue growth forecast for 2025-2027?

(NASDAQ: TBPH) Theravance Biopharma's forecast annual revenue growth rate of 15.59% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 102.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.86%.

Theravance Biopharma's revenue in 2025 is $80,327,000.On average, 8 Wall Street analysts forecast TBPH's revenue for 2025 to be $5,571,433,788, with the lowest TBPH revenue forecast at $5,323,138,877, and the highest TBPH revenue forecast at $5,778,177,307. On average, 8 Wall Street analysts forecast TBPH's revenue for 2026 to be $4,489,628,059, with the lowest TBPH revenue forecast at $4,072,036,555, and the highest TBPH revenue forecast at $5,097,139,834.

In 2027, TBPH is forecast to generate $6,286,421,790 in revenue, with the lowest revenue forecast at $4,221,013,502 and the highest revenue forecast at $8,406,556,303.

What is TBPH's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: TBPH) forecast ROA is 10.04%, which is lower than the forecast US Biotechnology industry average of 91.01%.

What is TBPH's Price Target?

According to 5 Wall Street analysts that have issued a 1 year TBPH price target, the average TBPH price target is $27.80, with the highest TBPH stock price forecast at $40.00 and the lowest TBPH stock price forecast at $20.00.

On average, Wall Street analysts predict that Theravance Biopharma's share price could reach $27.80 by Dec 3, 2026. The average Theravance Biopharma stock price prediction forecasts a potential upside of 57.86% from the current TBPH share price of $17.61.

What is TBPH's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: TBPH) Theravance Biopharma's current Earnings Per Share (EPS) is $0.58. On average, analysts forecast that TBPH's EPS will be $1.92 for 2025, with the lowest EPS forecast at $1.37, and the highest EPS forecast at $2.36. On average, analysts forecast that TBPH's EPS will be $0.96 for 2026, with the lowest EPS forecast at $0.19, and the highest EPS forecast at $1.37. In 2027, TBPH's EPS is forecast to hit $0.08 (min: -$0.87, max: $1.44).

What is TBPH's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: TBPH) forecast ROE is 17.92%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.